Sight Sciences, Inc., an ophthalmic medical device company, engages in the development and commercialization of surgical and nonsurgical technologies for the treatment of eye diseases. The company's products include OMNI Surgical System, a therapeutic device used by ophthalmic surgeons to reduce intraocular pressure in adult glaucoma patients; and TearCare System, a wearable eyelid technology for the treatment of dry eye disease (DED) for ophthalmologists and optometrists. It offers its products through sales representatives and distributors to hospitals, medical centers, and eyecare professionals in the United States. The company was incorporated in 2010 and is headquartered in Menlo Park, California.

Filer	Shares	Latest Filing Date	Previously owned	Change	Share-Type	Market Value
Kck Ltd.	4.65M	2023-07-25	4.72M	-64.40K	Shares	38.51M
Jackson Square Partners, Llc	1.72M	2023-08-11	1.28M	437.14K	Shares	14.21M
Apollo Management Holdings,...	671.52K	2023-12-01	0	671.52K	Shares	5.87M
Rtw Investments, Lp	0	2023-08-14	41.33K	-41.33K	Shares	0
State Of Wyoming	0	2023-08-14	5.46K	-5.46K	Shares	0

NASDAQ:SGHT

Sight Sciences, Inc.

Last Close

5.65

08/05 13:34

Market Cap

222.30M

Beta: -

Volume Today

4.63K

Avg: 124.66K

PE Ratio

−3.29

PFCF: −3.64

Institutional trades

Institutional Ownership

Current holdings institutionals